Charles Q. Meng

620 total citations
16 papers, 482 citations indexed

About

Charles Q. Meng is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Charles Q. Meng has authored 16 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Charles Q. Meng's work include Cell Adhesion Molecules Research (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Synthesis and biological activity (3 papers). Charles Q. Meng is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Synthesis and biological activity (3 papers). Charles Q. Meng collaborates with scholars based in Canada. Charles Q. Meng's co-authors include Liming Ni, James A. Sikorski, Martin A. Wasserman, Cynthia L. Sundell, Lee K. Hoong, Patricia K. Somers, Uday Saxena, Ki‐Ling Suen, Charles Kunsch and Xiaoxiang Zheng and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Charles Q. Meng

16 papers receiving 452 citations

Peers

Countries citing papers authored by Charles Q. Meng

Since Specialization

Citations

This map shows the geographic impact of Charles Q. Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Q. Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Q. Meng more than expected).

Fields of papers citing papers by Charles Q. Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Q. Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Q. Meng. The network helps show where Charles Q. Meng may publish in the future.

Co-authorship network of co-authors of Charles Q. Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Q. Meng. A scholar is included among the top collaborators of Charles Q. Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Q. Meng. Charles Q. Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Carboxylated, Heteroaryl-Substituted Chalcones as Inhibitors of Vascular Cell Adhesion Molecule-1 Expression for Use in Chronic Inflammatory Diseases 2007 ·Journal of Medicinal Chemistry ·Charles Q. Meng, Liming Ni, (unknown), Zhihong Ye, Melanie Weingarten, (unknown), (unknown), Elaine M. Marino, Ki‐Ling Suen, Charles Kunsch, (unknown), Randy B. Howard, Cynthia L. Sundell, Martin A. Wasserman, James A. Sikorski	42
2	Atherosclerosis is an Inflammatory Disorder After All 2006 ·Current Topics in Medicinal Chemistry ·Charles Q. Meng	10
3	AGIX-4207 [2-[4-[[1-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic Acid], a Novel Antioxidant and Anti-Inflammatory Compound: Cellular and Biochemical Characterization of Antioxidant Activity and Inhibition of Redox-Sensitive Inflammatory Gene Expression 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Charles Kunsch, Jayraz Luchoomun, (unknown), Geraldine L. Dodd, (unknown), Charles Q. Meng, Elaine M. Marino, (unknown), (unknown), Fei-Hua Qiu, James A. Sikorski, Patricia K. Somers, Ki‐Ling Suen, Suzanne Thomas, Anne M. Whalen, Martin A. Wasserman, Cynthia L. Sundell	9
4	Inflammation in Atherosclerosis: New Opportunities for Drug Discovery 2005 ·Mini-Reviews in Medicinal Chemistry ·Charles Q. Meng	4
5	Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-α-induced VCAM-1 expression 2004 ·Bioorganic & Medicinal Chemistry Letters ·Charles Q. Meng, Xiaoxiang Zheng, Liming Ni, Zhihong Ye, (unknown), (unknown), (unknown), Melanie Weingarten, (unknown), Joshua M. Gilmore, Lee K. Hoong, (unknown), Elaine M. Marino, Ki‐Ling Suen, Charles Kunsch, Martin A. Wasserman, James A. Sikorski	19
6	Recent advances in therapeutic chalcones 2004 ·Expert Opinion on Therapeutic Patents ·Liming Ni, Charles Q. Meng, James A. Sikorski	163
7	AGI-1067: A Multifunctional Phenolic Antioxidant, Lipid Modulator, Anti-Inflammatory and Antiatherosclerotic Agent 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Cynthia L. Sundell, Patricia K. Somers, Charles Q. Meng, Lee K. Hoong, Ki‐Ling Suen, (unknown), (unknown), Angela Chapman, Dustie N. Butteiger, (unknown), David G. Edwards, Alan Daugherty, Martin A. Wasserman, R. Wayne Alexander, Russell M. Medford, Uday Saxena	70
8	Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease 2003 ·The American Journal of Cardiology ·Martin A. Wasserman, Cynthia L. Sundell, Charles Kunsch, David G. Edwards, Charles Q. Meng, Russell M. Medford	33
9	Lead discovery of α,β-Unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expression 2003 ·Bioorganic & Medicinal Chemistry Letters ·Liming Ni, Xiaoxiang Zheng, Patricia K. Somers, Lee K. Hoong, (unknown), Elaine M. Marino, Ki‐Ling Suen, Uday Saxena, Charles Q. Meng	47
10	BO-653. Chugai. 2003 ·PubMed ·Charles Q. Meng	3
11	Novel Phenolic Antioxidants as Multifunctional Inhibitors of Inducible VCAM‐1 Expression for Use in Atherosclerosis. 2003 ·ChemInform ·Charles Q. Meng, (unknown)	3
12	Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis 2002 ·Bioorganic & Medicinal Chemistry Letters ·Charles Q. Meng, Patricia K. Somers, (unknown), (unknown), Lee K. Hoong, Xiaoxiang Zheng, (unknown), (unknown), (unknown), Charles Kunsch, Cynthia L. Sundell, Sampath Parthasarathy, Uday Saxena, James A. Sikorski, Martin A. Wasserman	49
13	Nitrobenzene Compounds Inhibit Expression of VCAM-1 2001 ·Bioorganic & Medicinal Chemistry Letters ·Charles Q. Meng, Xiaoxiang Zheng, (unknown), Lee K. Hoong, Patricia K. Somers, (unknown), Uday Saxena	6
14	5-Thienyltryptamine derivatives as serotonin 5-HT 1B/1D receptor agonists: potential treatments for migraine 2000 ·Bioorganic & Medicinal Chemistry Letters ·Charles Q. Meng, Suman Rakhit, David K.H. Lee, Rajender K. Kamboj, Kirk McCallum, (unknown), (unknown), Abdelmalik Slassi	3
15	5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Abdelmalik Slassi, Louise Edwards, (unknown), Charles Q. Meng, (unknown), (unknown), David K.H. Lee, (unknown), (unknown), (unknown), Hong Wang, Rajender K. Kamboj, Suman Rakhit	12
16	Migraine: Current Drug Discovery Trend 1997 ·Current Medicinal Chemistry ·Charles Q. Meng	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact